Europe Hospital-Acquired Infection Diagnostics Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Consumables and Instrument), By Infection Type, By Application, By Test Type, By End User, By Country and Growth Forecast, 2022 - 2028

The Europe Hospital-Acquired Infection Diagnostics Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).

In identifying the likely source of infection and exposing evidence of organ dysfunction, laboratory testing supports the clinical and history examination. Lactic acid, prothrombin time, liver transaminases, blood urea nitrogen (BUN), and serum creatinine levels can all be used to back up clinical hypoperfusion findings. Low or high white cell counts, raised bands, hypoglycemia, thrombocytopenia, hyperglycemia, and impaired mixed venous blood saturation are all relevant test results. Collecting samples for cultures prior to starting antibiotics is critical for determining the pathogen and antimicrobial susceptibility pattern immediately on. The pathogen's vulnerability as well as the antibiotic's vulnerability assist narrow the field from broad-spectrum antibiotics to pathogen-specific medicines. Investigations that do not change clinical decision-making or the course of treatment are generally not advised. C-reactive protein (CRP) and procalcitonin tests are deemed auxiliary and not advised if the pre-test probability of a HAI like ventilator-associated pneumonia/VAP is high. For instance, recent IDSA guidelines advocate tracheal aspirates for patients with HAP/VAP because it have been demonstrated to have a non-inferior yield when matched to invasive sampling methods like bronchoscopy or quantitative tracheal lavage.

The Europe region is being suffered from hospital-acquired infections and those infections are fatal in the nature, which increases the importance of hospital-acquired infection diagnostics system. Between 2016 and 2017, 310,755 patients from 1,209 acute care hospitals in 28 countries participated in point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial usage in the European Union and European Economic Area (EU/EEA). After nationwide validation, it was estimated that 6.5 percent of patients in acute care hospitals had at least one HAI. In acute care hospitals, 98,166 patients had a HAI on any given day, and 3.8 million patients had a HAI each year.

A European investigation of HCAIs linked to respiratory infection reported an incidence rate of 7.59 percent in the United Kingdom and Ireland. Pneumonia accounted for 15.7 percent of the HCAIs, whereas lower respiratory tract infections apart from pneumonia accounted for 7%. Artificial ventilation was used by approximately 21% of patients in both groups, which was much greater than the remainder of the HCAI patients. For both pneumonia and LRTIOP, the main invading bacterium was MRSA. LRTIOP patients had more C.

The Germany market dominated the Europe Hospital-Acquired Infection Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $358.1 million by 2028. The UK market is anticipated to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 7.9% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Consumables and Instrument. Based on Infection Type, the market is segmented into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and Others. Based on Application, the market is segmented into Drug-Resistance Testing and Disease Testing. Based on Test Type, the market is segmented into Molecular Diagnostics, Immunoassay, and Urinalysis. Based on End User, the market is segmented into Hospital, Standalone Laboratories, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Hospital-Acquired Infection Diagnostics Market Size will Hit $5.6 Billion by 2028, at a CAGR of 7.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG (Bayer Schering Pharma AG), Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Ecolab, Inc., Pfizer, Inc., Steris PLC, Johnson & Johnson, Abbott Laboratories, and Merck Group.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Reagents & Consumables
• Instrument

By Infection Type

• Urinary Tract Infections (UTI)
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Others

By Application

• Drug-Resistance Testing
• Disease Testing

By Test Type

• Molecular Diagnostics
• Immunoassay
• Urinalysis

By End User

• Hospital
• Standalone Laboratories
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG (Bayer Schering Pharma AG)
• Danaher Corporation
• Becton, Dickinson and Company
• Hologic, Inc.
• Ecolab, Inc.
• Pfizer, Inc.
• Steris PLC
• Johnson & Johnson
• Abbott Laboratories
• Merck Group

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 Europe Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 Europe Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 Europe Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 Europe Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 Europe Hospital-Acquired Infection Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Hospital-Acquired Infection Diagnostics Market by Product
4.1 Europe Reagents & Consumables Market by Country
4.2 Europe Instrument Market by Country

Chapter 5. Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 Europe Urinary Tract Infections (UTI) Market by Country
5.2 Europe Hospital Acquired Pneumonia Market by Country
5.3 Europe Bloodstream Infections Market by Country
5.4 Europe Surgical Site Infections Market by Country
5.5 Europe Gastrointestinal Infections Market by Country
5.6 Europe Others Market by Country

Chapter 6. Europe Hospital-Acquired Infection Diagnostics Market by Application
6.1 Europe Drug-Resistance Testing Market by Country
6.2 Europe Disease Testing Market by Country

Chapter 7. Europe Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 Europe Molecular Diagnostics Market by Country
7.2 Europe Immunoassay Market by Country
7.3 Europe Urinalysis Market by Country

Chapter 8. Europe Hospital-Acquired Infection Diagnostics Market by End User
8.1 Europe Hospital Market by Country
8.2 Europe Standalone Laboratories Market by Country
8.3 Europe Others Market by Country

Chapter 9. Europe Hospital-Acquired Infection Diagnostics Market by Country
9.1 Germany Hospital-Acquired Infection Diagnostics Market
9.1.1 Germany Hospital-Acquired Infection Diagnostics Market by Product
9.1.2 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.3 Germany Hospital-Acquired Infection Diagnostics Market by Application
9.1.4 Germany Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.5 Germany Hospital-Acquired Infection Diagnostics Market by End User
9.2 UK Hospital-Acquired Infection Diagnostics Market
9.2.1 UK Hospital-Acquired Infection Diagnostics Market by Product
9.2.2 UK Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.3 UK Hospital-Acquired Infection Diagnostics Market by Application
9.2.4 UK Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.5 UK Hospital-Acquired Infection Diagnostics Market by End User
9.3 France Hospital-Acquired Infection Diagnostics Market
9.3.1 France Hospital-Acquired Infection Diagnostics Market by Product
9.3.2 France Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.3 France Hospital-Acquired Infection Diagnostics Market by Application
9.3.4 France Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.5 France Hospital-Acquired Infection Diagnostics Market by End User
9.4 Russia Hospital-Acquired Infection Diagnostics Market
9.4.1 Russia Hospital-Acquired Infection Diagnostics Market by Product
9.4.2 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.3 Russia Hospital-Acquired Infection Diagnostics Market by Application
9.4.4 Russia Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.5 Russia Hospital-Acquired Infection Diagnostics Market by End User
9.5 Spain Hospital-Acquired Infection Diagnostics Market
9.5.1 Spain Hospital-Acquired Infection Diagnostics Market by Product
9.5.2 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type
9.5.3 Spain Hospital-Acquired Infection Diagnostics Market by Application
9.5.4 Spain Hospital-Acquired Infection Diagnostics Market by Test Type
9.5.5 Spain Hospital-Acquired Infection Diagnostics Market by End User
9.6 Italy Hospital-Acquired Infection Diagnostics Market
9.6.1 Italy Hospital-Acquired Infection Diagnostics Market by Product
9.6.2 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type
9.6.3 Italy Hospital-Acquired Infection Diagnostics Market by Application
9.6.4 Italy Hospital-Acquired Infection Diagnostics Market by Test Type
9.6.5 Italy Hospital-Acquired Infection Diagnostics Market by End User
9.7 Rest of Europe Hospital-Acquired Infection Diagnostics Market
9.7.1 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product
9.7.2 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
9.7.3 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application
9.7.4 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type
9.7.5 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User

Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements

TABLE 1 Europe Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Europe Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hospital-Acquired Infection Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Hospital-Acquired Infection Diagnostics Market
TABLE 5 Acquisition and Mergers– Hospital-Acquired Infection Diagnostics Market
TABLE 6 Approvals and Trials - Hospital-Acquired Infection Diagnostics Market
TABLE 7 Europe Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 8 Europe Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 9 Europe Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Instrument Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Instrument Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 14 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 15 Europe Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 28 Europe Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 29 Europe Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 34 Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 35 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 42 Europe Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 43 Europe Hospital Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Hospital Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 49 Europe Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 50 Europe Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 51 Germany Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 52 Germany Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 53 Germany Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 54 Germany Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 55 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 56 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 57 Germany Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 58 Germany Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 59 Germany Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 60 Germany Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 61 Germany Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 62 Germany Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 63 UK Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 UK Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 UK Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 66 UK Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 67 UK Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 68 UK Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 69 UK Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 70 UK Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 71 UK Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 72 UK Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 73 UK Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 74 UK Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 75 France Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 76 France Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 77 France Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 78 France Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 79 France Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 80 France Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 81 France Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 82 France Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 83 France Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 84 France Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 85 France Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 86 France Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 87 Russia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 88 Russia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 89 Russia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 90 Russia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 91 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 92 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 93 Russia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 94 Russia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 95 Russia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 Russia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 Russia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 98 Russia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 99 Spain Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 100 Spain Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 101 Spain Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 102 Spain Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 103 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 104 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 105 Spain Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 106 Spain Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 107 Spain Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 108 Spain Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 109 Spain Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 110 Spain Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 111 Italy Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 112 Italy Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 113 Italy Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 114 Italy Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 115 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 116 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 117 Italy Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 118 Italy Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 119 Italy Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 120 Italy Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 121 Italy Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 122 Italy Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 123 Rest of Europe Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 124 Rest of Europe Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 125 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 126 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 133 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 134 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 135 Key Information – Bayer AG
TABLE 136 Key Information – Danaher Corporation
TABLE 137 Key information – Becton, Dickinson and Company
TABLE 138 Key information – Hologic, Inc.
TABLE 139 Key Information – Ecolab, Inc.
TABLE 140 Key Information – Pfizer, Inc.
TABLE 141 key information – Steris PLC
TABLE 142 Key information – Johnson & Johnson
TABLE 143 Key Information – Abbott Laboratories
TABLE 144 key Information – Merck GrouP

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent Strategies and Developments: Becton, Dickinson and Company
FIG 5 Recent Strategies and Developments: Hologic, Inc.
FIG 6 Recent Strategies and Developments: Ecolab, Inc.
FIG 7 Recent Strategies and Developments: Pfizer, Inc.
FIG 8 Recent Strategies and Developments: Abbott Laboratories